These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 9117128

  • 1. The effects of recombinant human granulocyte-colony stimulating factor on vascular dysfunction and splanchnic ischaemia-reperfusion injury.
    Squadrito F, Altavilla D, Squadrito G, Campo GM, Ioculano M, Ammedolia L, Arlotta M, Saitta A, Caputi AP.
    Br J Pharmacol; 1997 Jan; 120(2):333-9. PubMed ID: 9117128
    [Abstract] [Full Text] [Related]

  • 2. Effects of S-ethylisothiourea, a potent inhibitor of nitric oxide synthase, alone or in combination with a nitric oxide donor in splanchnic artery occlusion shock.
    Squadrito F, Altavilla D, Squadrito G, Campo GM, Ioculano M, Canale P, Rossi F, Saitta A, Caputi AP.
    Br J Pharmacol; 1996 Sep; 119(1):23-8. PubMed ID: 8872352
    [Abstract] [Full Text] [Related]

  • 3. Tacrolimus suppresses tumour necrosis factor-alpha and protects against splanchnic artery occlusion shock.
    Squadrito F, Altavilla D, Squadrito G, Ferlito M, Campo GM, Arlotta M, Grimaldi S, Quartarone C, Saitta A, Caputi AP.
    Br J Pharmacol; 1999 May; 127(2):498-504. PubMed ID: 10385251
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Improved survival and reversal of endothelial dysfunction by the 21-aminosteroid, U-74389G in splanchnic ischaemia-reperfusion injury in the rat.
    Squadrito F, Altavilla D, Ammendolia L, Squadrito G, Campo GM, Sperandeo A, Canale P, Ioculano M, Saitta A, Caputi AP.
    Br J Pharmacol; 1995 Jun; 115(3):395-400. PubMed ID: 7582448
    [Abstract] [Full Text] [Related]

  • 6. The involvement of tumour necrosis factor-alpha in the protective effects of 17 beta oestradiol in splanchnic ischaemia-reperfusion injury.
    Squadrito F, Altavilla D, Squadrito G, Campo GM, Arlotta M, Arcoraci V, Minutoli L, Saitta A, Caputi AP.
    Br J Pharmacol; 1997 Aug; 121(8):1782-8. PubMed ID: 9283718
    [Abstract] [Full Text] [Related]

  • 7. Contribution of intercellular adhesion molecule 1 (ICAM-1) to the pathogenesis of splanchnic artery occlusion shock in the rat.
    Squadrito F, Altavilla D, Canale P, Ioculano MP, Campo GM, Ammendolia L, Squadrito G, Saitta A, Calapai G, Caputi AP.
    Br J Pharmacol; 1994 Nov; 113(3):912-6. PubMed ID: 7858885
    [Abstract] [Full Text] [Related]

  • 8. Adrenocorticotropin reverses vascular dysfunction and protects against splanchnic artery occlusion shock.
    Squadrito F, Guarini S, Altavilla D, Squadrito G, Campo GM, Arlotta M, Quartarone C, Saitta A, Cucinotta D, Bazzani C, Cainazzo MM, Mioni C, Bertolini A, Caputi AP.
    Br J Pharmacol; 1999 Oct; 128(3):816-22. PubMed ID: 10516667
    [Abstract] [Full Text] [Related]

  • 9. Participation of tumour necrosis factor and nitric oxide in the mediation of vascular dysfunction in splanchnic artery occlusion shock.
    Squadrito F, Altavilla D, Canale P, Ioculano M, Campo GM, Ammendolia L, Ferlito M, Zingarelli B, Squadrito G, Saitta A.
    Br J Pharmacol; 1994 Dec; 113(4):1153-8. PubMed ID: 7889268
    [Abstract] [Full Text] [Related]

  • 10. Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion.
    Cuzzocrea S, Zingarelli B, Costantino G, Szabó A, Salzman AL, Caputi AP, Szabó C.
    Br J Pharmacol; 1997 Jul; 121(6):1065-74. PubMed ID: 9249240
    [Abstract] [Full Text] [Related]

  • 11. Protective effects of cyclosporin-A in splanchnic artery occlusion shock.
    Squadrito F, Altavilla D, Squadrito G, Ferlito M, Deodato B, Arlotta M, Minutoli L, Campo GM, Bova A, Quartarone C, Urna G, Sardella A, Saitta A, Caputi AP.
    Br J Pharmacol; 2000 May; 130(2):339-44. PubMed ID: 10807671
    [Abstract] [Full Text] [Related]

  • 12. Sulfatide reduces leucocyte accumulation and reverts vascular failure in splanchnic artery occlusion shock.
    Squadrito F, Altavilla D, Squadrito G, Campo GM, Arlotta M, Quartarone C, Minutoli L, Ferlito M, Saitta A, Caputi AP.
    Eur J Pharmacol; 1998 Nov 13; 361(1):101-8. PubMed ID: 9851547
    [Abstract] [Full Text] [Related]

  • 13. TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against splanchnic artery occlusion shock.
    Canale P, Squadrito F, Altavilla D, Ioculano M, Zingarelli B, Campo GM, Urna G, Sardella A, Squadrito G, Caputi AP.
    Agents Actions; 1994 Oct 13; 42(3-4):128-34. PubMed ID: 7879698
    [Abstract] [Full Text] [Related]

  • 14. E-selectin involvement in the pathogenesis of splanchnic artery occlusion shock.
    Altavilla D, Squadrito F, Canale P, Ioculano M, Campo GM, Squadrito G, Ammendolia L, Caputi AP.
    Eur J Pharmacol; 1995 Jan 16; 272(2-3):223-9. PubMed ID: 7536163
    [Abstract] [Full Text] [Related]

  • 15. Monocytes and lymphocytes as active participants in the pathogenesis of experimental shock.
    Altavilla D, Squadrito F, Ammendolia L, Squadrito G, Campo GM, Canale P, Ioculano M, Musolino C, Alonci A, Sardella A, Urna G, Saitta A, Caputi AP.
    Inflamm Res; 1996 Aug 16; 45(8):398-404. PubMed ID: 8872513
    [Abstract] [Full Text] [Related]

  • 16. Recombinant human granulocyte colony-stimulating factor reverts vascular dysfunction.
    Squadrito F, Altavilla D, Squadrito G, Campo GM, Ioculano M, Serranò M, Minutoli L, Arlotta M, Musolino C, Saitta A, Caputi AP.
    Int J Microcirc Clin Exp; 1997 Aug 16; 17(1):10-4. PubMed ID: 9176720
    [Abstract] [Full Text] [Related]

  • 17. Tumor necrosis factor induces E-selectin production in splanchnic artery occlusion shock.
    Altavilla D, Squadrito F, Canale P, Ioculano M, Campo GM, Squadrito G, Saitta A, Caputi AP.
    Am J Physiol; 1995 Apr 16; 268(4 Pt 2):H1412-7. PubMed ID: 7537468
    [Abstract] [Full Text] [Related]

  • 18. Beneficial effects of GPI 6150, an inhibitor of poly(ADP-ribose) polymerase in a rat model of splanchnic artery occlusion and reperfusion.
    Mazzon E, Dugo L, De SA, Li JH, Caputi AP, Zhang J, Cuzzocrea S.
    Shock; 2002 Mar 16; 17(3):222-7. PubMed ID: 11900342
    [Abstract] [Full Text] [Related]

  • 19. Passive immunization with antibodies against tumor necrosis factor (TNF-alpha) protects from the lethality of splanchnic artery occlusion shock.
    Squadrito F, Altavilla D, Ioculano M, Calapai G, Zingarelli B, Saitta A, Campo GM, Rizzo A, Caputi AP.
    Circ Shock; 1992 Jul 16; 37(3):236-44. PubMed ID: 1423915
    [Abstract] [Full Text] [Related]

  • 20. Beneficial effects of BAY u3405, a novel thromboxane A2 receptor antagonist, in splanchnic artery occlusion shock.
    Canale P, Squadrito F, Altavilla D, Ioculano M, Campo GM, Squadrito G, Urna G, Sardella A, Caputi AP.
    Pharmacology; 1994 Dec 16; 49(6):376-85. PubMed ID: 7878075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.